The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response

International Journal of Neuropsychopharmacology

Volumn 15, Issue 9, 2012, Pages 1205-1215

  Lennertz, Leonhard ^a   Quednow, Boris B ^b   Schuhmacher, Anna ^a   Petrovsky, Nadine ^a   Frommann, Ingo ^a   Schulze Rauschenbach, Svenja ^a   Landsberg, Martin W ^a   Steinbrecher, Anja ^a   Höfels, Susanne ^a   Pukrop, Ralf ^c   Klosterkötter, Joachim ^c   Franke, Petra E ^d   Wölwer, Wolfgang ^d   Gaebel, Wolfgang ^d   Häfner, Heinz ^e   Maier, Wolfgang ^a   Wagner, Michael ^a   Mössner, Rainald ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Department of Orthopedic Surgery   (Germany)

^e CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Acoustic startle; antipsychotic drugs; memory; neuropeptide S; schizophrenia

Indexed keywords

ASPARAGINE; ISOLEUCINE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S; NEUROPEPTIDE S RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GAIN OF FUNCTION MUTATION; GENETIC VARIABILITY; GENOTYPE; HABITUATION; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY CONSOLIDATION; MENTAL PATIENT; PANIC; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STARTLE REFLEX; VERBAL MEMORY;

ACOUSTIC STIMULATION; ADULT; ALGORITHMS; AMINO ACID SUBSTITUTION; ANALYSIS OF VARIANCE; ASPARAGINE; BLINKING; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DNA; FEMALE; GENOTYPE; HUMANS; ISOLEUCINE; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, G-PROTEIN-COUPLED; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SENSORY GATING; STARTLE REACTION;

EID: 84871508776     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001623     Document Type: Article

References (45)

1. Aleman A, Hijman R, de Haan EH, Kahn RS (1999). Memory impairment in schizophrenia: a meta-analysis. American Journal of Psychiatry 156, 1358-1366.
2. Amrhein C, Pauli P, Dengler W, Wiedemann G (2005). Covariation bias and its physiological correlates in panic disorder patients. Journal of Anxiety Disorders 19, 177-191.
3. APA 1994). Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
4. Arnt J, Skarsfeldt T (1998). Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18, 63-101.
5. Arranz MJ, de Leon J (2007). Pharmacogenetics and pharmacogenomics of schizophrenia : a review of last decade of research. Molecular Psychiatry 12, 707-747.
6. Becker T, Knapp M (2004). Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genetic Epidemiology 27, 21-32.
7. Bernier V, Stocco R, Bogusky MJ, Joyce JG, et al. (2006). Structure-function relationships in the neuropeptide S receptor : molecular consequences of the asthma-associated mutation N107I. Journal of Biological Chemistry 281, 24704-24712.
8. Braff DL, Geyer MA, Light GA, Sprock J, et al. (2001). Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophrenia Research 49, 171-178.
9. Braff DL, Grillon C, Geyer MA (1992). Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry 49, 206-215.
10. Carlsson A (1978). Antipsychotic drugs, neurotransmitters, and schizophrenia. American Journal of Psychiatry 135, 165-173.
11. Domschke K, Reif A, Weber H, Richter J, et al. (2010). Neuropeptide S receptor gene-converging evidence for a role in panic disorder. Molecular Psychiatry 16, 938-948.
12. Duangdao DM, Clark SD, Okamura N, Reinscheid RK (2009). Behavioral phenotyping of neuropeptide S receptor knockout mice. Behavioural Brain Research 205, 1-9.
13. Favaron E, Bellodi L, Biffi S, Vanni G, et al. (2010). Acoustic startle response in panic disorder. Psychiatry Research 176, 254-256.
14. Fendt M, Buchi M, Burki H, Imobersteg S, et al. (2011). Neuropeptide S receptor deficiency modulates spontaneous locomotor activity and the acoustic startle response. Behavioural Brain Research 217, 1-9.
15. Fendt M, Imobersteg S, Burki H, McAllister KH, et al. (2010). Intra-amygdala injections of neuropeptide S block fear-potentiated startle. Neuroscience Letters 474, 154-157.
16. Geffen G, Moar KJ, O'Hanlon AP, Clark CR, et al. (1990). Performance measures of 16-to 86-year-old males and females on the auditory verbal learning test. Clinical Neuropsychologist 4, 45-63.
17. Geyer MA, Braff DL (1982). Habituation of the Blink reflex in normals and schizophrenic patients. Psychophysiology 19, 1-6.
18. Geyer MA, Ellenbroek B (2003). Animal behavior models of the mechanisms underlying antipsychotic atypicality. Progress in Neuro-Psychopharmacology and Biological Psychiatry 27, 1071-1079.
19. Grillon C, Ameli R, Goddard A, Woods SW, et al. (1994). Baseline and fear-potentiated startle in panic disorder patients. Biological Psychiatry 35, 431-439.
20. Hammer TB, Oranje B, Fagerlund B, Bro H, et al. (2011). Stability of prepulse inhibition and habituation of the startle reflex in schizophrenia : a 6-year follow-up study of initially antipsychotic-naive, first-episode schizophrenia patients. International Journal of Neuropsychopharmacology 14, 913-925.
21. Heinrichs RW, Zakzanis KK (1998). Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12, 426-445.
22. Helmstaedter C, Lendt M, Lux S (2001). VLMT-Verbaler Lern-und Merkfähigkeitstest Manual. Göttingen : Beltz.
23. Howes OD, Kapur S (2009). The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophrenia Bulletin 35, 549-562.
24. Jüngling K, Seidenbecher T, Sosulina L, Lesting J, et al. 2008 Neuropeptide S-mediated control of fear expression and extinction : role of intercalated GABAergic neurons in the amygdala. Neuron. 59, 298-310
25. Kay SR, Opler LA, Fiszbein A (1992). Positive and Negative Syndrome Scale (PANSS). Manual. North Tonawanda, NY: Multi-Health Systems Inc.
26. Kumari V, Gray JA (1999). Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex. Psychopharmacology (Berlin) 141, 11-15.
27. Lehrl S, Merz J, Burkhard G, Fischer S (1999). Mehrfachwahl-Wortschatz- Intelligenztest. Göttingen : Hogrefe.
28. Leonard SK, Dwyer JM, Sukoff Rizzo SJ, Platt B, et al. (2008). Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology (Berlin) 197, 601-611.
29. McTeague LM, Lang PJ, Laplante MC, Bradley MM (2011). Aversive imagery in panic disorder : agoraphobia severity, comorbidity, and defensive physiology. Biological Psychiatry 70, 415-424.
30. Meincke U, Light GA, Geyer MA, Braff DL, et al. (2004). Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia. Psychiatry Research 126, 51-61.
31. Moriwaki M, Kishi T, Takahashi H, Hashimoto R, et al. (2009). Prepulse inhibition of the startle response with chronic schizophrenia : a replication study. Neuroscience Research 65, 259-262.
32. Okamura N, Garau C, Duangdao DM, Clark SD, et al. (2010a). Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain. Neuropsychopharmacology 36, 744-752.
33. Okamura N, Hashimoto K, Iyo M, Shimizu E, et al. (2007). Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/ hyperactivity disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31, 1444-1448.
34. Okamura N, Reinscheid RK, Ohgake S, Iyo M, et al. (2010b). Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801. Neuropharmacology 58, 166-172.
35. Quednow BB, Frommann I, Berning J, Kuhn KU, et al. (2008). Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biological Psychiatry 64, 766-773.
36. Quednow BB, Kuhn KU, Beckmann K, Westheide J, et al. (2006a). Attenuation of the prepulse inhibition of the acoustic startle response within and between sessions. Biological Psychology 71, 256-263.
37. Quednow BB, Wagner M, Westheide J, Beckmann K, et al. (2006b). Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine. Biological Psychiatry 59, 536-545.
38. Reinscheid RK (2008). Neuropeptide S: anatomy, pharmacology, genetics and physiological functions. Results and Problems in Cell Differentiation 46, 145-158.
39. Reinscheid RK, Xu YL (2005a). Neuropeptide S and its receptor : a newly deorphanized G protein-coupled receptor system. Neuroscientist 11, 532-538.
40. Reinscheid RK, Xu YL (2005b). Neuropeptide S as a novel arousal promoting peptide transmitter. FEBS Journal 272, 5689-5693.
41. Reinscheid RK, Xu YL, Civelli O (2005a). Neuropeptide S: a new player in the modulation of arousal and anxiety. Molecular Interventions 5, 42-46.
42. Reinscheid RK, Xu YL, Okamura N, Zeng J, et al. (2005b). Pharmacological characterization of human and murine neuropeptide S receptor variants. Journal of Pharmacology and Experimental Therpeutics 315, 1338-1345.
43. Rizzi A, Vergura R, Marzola G, Ruzza C, et al. (2008). Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. British Journal of Pharmacology 154, 471-479.
44. WHO (1992). International Classification of Disease, Tenth Revision. Geneva, Switzerland: World Health Organisation.
45. Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, et al. (2004). Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43, 487-497.